A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

Dan Peer, a global pioneer in mRNA drug development and director of the Laboratory of ... is an mRNA-based vaccine delivered ...

Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...

COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...

COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...

NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent ...

Partial immunity from COVID in residents early in the pandemic and infection-prevention measures may explain the findings, ...

Health officials have set targets for how good and how safe a COVID-19 vaccine needs to be, but communicating that to the public can present challenges.

Novavax wins narrowed approval for its Covid-19 shot after delay Federal health officials led by RFK Jr. are subjecting Covid shots to greater scrutiny Alastair Grant/AP By Helen Branswell May 17 ...

The company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine. Moderna (NASDAQ: MRNA), the next-generation healthcare company most famous for developing the ...